Health Care & Life Sciences » Biotechnology | Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc. | Income Statement

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
32,053.00
47,741.00
160,880.00
88,268.00
102,814.00
206,625
SG&A Expense
22,803.00
28,404.00
36,093.00
55,766.00
76,063.00
115,779
EBIT
9,029.00
18,985.00
124,148.00
30,841.00
24,614.00
88,328
Unusual Expense
-
166.00
347.00
29.00
159.00
59
Non Operating Income/Expense
381.00
-
-
-
-
-
Interest Expense
31.00
18.00
8.00
45.00
40.00
-
Pretax Income
9,627.00
19,268.00
125,455.00
32,560.00
26,947.00
93,121
Income Tax
-
15,170.00
46,463.00
10,894.00
9,237.00
21,165
Consolidated Net Income
4,043.00
34,438.00
78,992.00
21,666.00
17,710.00
71,956
Net Income
4,043.00
34,438.00
78,992.00
21,666.00
17,710.00
71,956
Net Income After Extraordinaries
4,043.00
34,438.00
78,992.00
21,666.00
17,710.00
71,956
Net Income Available to Common
6,569.00
34,438.00
78,992.00
21,666.00
17,710.00
71,956
EPS (Basic)
0.67
1.80
4.09
1.13
0.91
3.48
Basic Shares Outstanding
9,788.00
18,354.80
18,673.50
18,929.00
19,066.00
19,255
EPS (Diluted)
0.67
1.80
4.09
1.13
0.91
3.48
Diluted Shares Outstanding
9,788.00
19,185.20
19,294.60
19,224.00
19,407.00
20,650
EBITDA
9,250.00
19,337.00
124,787.00
32,502.00
26,751.00
90,846
Non-Operating Interest Income
248.00
467.00
968.00
1,735.00
2,532.00
4,852
Other After Tax Income (Expense)
13,670.00
-
-
-
-
-
Preferred Dividends
2,526.00
-
-
-
-
-

About Enanta Pharmaceuticals

View Profile
Address
500 Arsenal Street
Watertown Massachusetts 02472
United States
Employees -
Website http://www.enanta.com
Updated 07/08/2019
Enanta Pharmaceuticals, Inc. engages in the research and development of small molecule drugs for the treatment of viral infections and liver diseases. It offers the two protease inhibitors Maviret and the Viekira Pak for the treatment of chronic hepatitis C virus. The company was founded by Peter O.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.